NeuTherapeutics
Phase 2We strive for Precision Medicine, Personalized Treatment and Predictive outcomes.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $18.2M
About
We strive for Precision Medicine, Personalized Treatment and Predictive outcomes.
Small Molecules
Funding History
2Total raised:$18.2M
Series A$15MMar 15, 2022
Seed$3.2MSep 15, 2020